Microba Life Sciences Limited (ASX:MAP)
Australia · Delayed Price · Currency is AUD 0.0860
+0.0010 (1.18%)
Feb 26, 2026, 3:47 PM AEST
Microba Life Sciences Market Cap
Microba Life Sciences has a market cap or net worth of 51.76 million as of February 25, 2026. Its market cap has decreased by -57.97% in one year.
Market Cap
51.76M
Enterprise Value
43.12M
Revenue
15.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
Market Cap Chart
Since April 5, 2022, Microba Life Sciences's market cap has decreased from 96.03M to 51.76M, a decrease of -46.10%. That is a compound annual growth rate of -14.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 24, 2026 | 52.98M | 14.47% |
| Dec 31, 2025 | 46.28M | -47.00% |
| Dec 31, 2024 | 87.33M | 8.33% |
| Dec 29, 2023 | 80.61M | -29.31% |
| Dec 30, 2022 | 114.03M | 18.75% |
| Apr 5, 2022 | 96.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Integral Diagnostics | 898.24M |
| Healius | 501.03M |
| Australian Clinical Labs | 430.58M |
| Monash IVF Group | 282.49M |
| Rhythm Biosciences | 67.12M |
| Cryosite | 58.57M |
| INOVIQ | 47.16M |
| BCAL Diagnostics | 46.01M |